What changed
$MET — HOLD 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $19.1B | EPS $2.42 vs $2.27 🟢
💡 Consensus expected EPS of 2.27; actual 2.42. Market appears to have already discounted the beat. The variant view is that the stock is fairly valued and lacks positive catalysts; the market may be pricing in earnings normalization rather than sustained improvement.
📉 Reward/risk: 0.8:1
🏢 Business Quality: 6/10 - well-diversified large-cap life insurer with stable cash flows but low growth and high regulatory exposure
📊 Valuation: fair - current P/E 16.8x at 50th percentile of historical range, in line with peer multiples; P/B likely near 1.0x, not cheap on multiple measures
🔮 Catalyst: N/A - recent earnings report is backward-looking
💰 Entry: $88.27, stop $80, target $95
📊 Our read: HOLD. Full analysis →
https://stockduty.xyz/s/MET0623